Skip to main content
Erschienen in:

22.10.2016

Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period

verfasst von: Kalin Vidinov, Dragomira Nikolova

Erschienen in: Endocrine Pathology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

In recent years, there are numerous reports indicating the presence of familial papillary carcinoma. Unfortunately, no genetic defect can be linked directly to the disease. In this study, we set the goal to make a retrospective analysis of the cases with papillary carcinoma in the Department of Endocrine Surgery for the past 10 years, to compare the characteristics of sporadic and familial forms of the disease and to find families with hereditary papillary carcinoma. The study included 810 patients treated for thyroid cancer in the Department of Endocrine Surgery, USBALE “Acad. Iv. Penchev” Hospital, between January 1, 2006 and December 31, 2015. We used chi square test to determine statistical significant difference. The data analysis and interpretation was performed on SPSS 20.0. Both groups had similar demographic distribution. We found that 587 patients have sporadic papillary carcinoma, while 147 have a relative with thyroid pathology in the first degree of kinship. In 8 patients, there was a blood relative with thyroid cancer. When we compared the two groups, we found statistically significant difference only in tumor size. There was no significant difference in aggressiveness of the thyroid cancer (multifocality and lymph node metastasis). When analyzing the results, we identified 147 patients with a family history of thyroid disease (20%). In 8 patients (5.44%), we found at least one relative with papillary thyroid carcinoma. However, our study does not demonstrate any difference in the aggressiveness of familial and sporadic papillary thyroid carcinoma.
Literatur
2.
Zurück zum Zitat Eng C (2000) Familial Papillary Thyroid Cancer—Many Syndromes, Too Many Genes? The Journal of Clinical Endocrinology & Metabolism 85 (5):1755–1757. doi:10.1210/jcem.85.5.6632 Eng C (2000) Familial Papillary Thyroid Cancer—Many Syndromes, Too Many Genes? The Journal of Clinical Endocrinology & Metabolism 85 (5):1755–1757. doi:10.​1210/​jcem.​85.​5.​6632
3.
Zurück zum Zitat Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH, Klempnauer J (2000) Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World journal of surgery 24 (11):1409–1417CrossRefPubMed Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH, Klempnauer J (2000) Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World journal of surgery 24 (11):1409–1417CrossRefPubMed
4.
Zurück zum Zitat Mihajlovic-Bozic V, Tatic S, Paunovic I, Jankovic R, Havelka M (2000) Familial papillary thyroid carcinoma. Archive of Oncology 8 (3):135–136 Mihajlovic-Bozic V, Tatic S, Paunovic I, Jankovic R, Havelka M (2000) Familial papillary thyroid carcinoma. Archive of Oncology 8 (3):135–136
5.
Zurück zum Zitat Bano G, Hodgson S (2016) Diagnosis and Management of Hereditary Thyroid Cancer. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 205:29–44. doi:10.1007/978-3-319-29998-3_3 PubMed Bano G, Hodgson S (2016) Diagnosis and Management of Hereditary Thyroid Cancer. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 205:29–44. doi:10.​1007/​978-3-319-29998-3_​3 PubMed
6.
Zurück zum Zitat Rios A, Rodriguez JM, Navas D, Cepero A, Torregrosa NM, Balsalobre MD, Parrilla P (2016) Family Screening in Familial Papillary Carcinoma: The Early Detection of Thyroid Disease. Annals of surgical oncology 23 (8):2564–2570. doi:10.1245/s10434-016-5149-8 CrossRefPubMed Rios A, Rodriguez JM, Navas D, Cepero A, Torregrosa NM, Balsalobre MD, Parrilla P (2016) Family Screening in Familial Papillary Carcinoma: The Early Detection of Thyroid Disease. Annals of surgical oncology 23 (8):2564–2570. doi:10.​1245/​s10434-016-5149-8 CrossRefPubMed
7.
Zurück zum Zitat Rowland KJ, Moley JF (2015) Hereditary thyroid cancer syndromes and genetic testing. Journal of surgical oncology 111 (1):51–60CrossRefPubMed Rowland KJ, Moley JF (2015) Hereditary thyroid cancer syndromes and genetic testing. Journal of surgical oncology 111 (1):51–60CrossRefPubMed
8.
Zurück zum Zitat Sung TY, Lee YM, Yoon JH, Chung KW, Hong SJ (2015) Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases. World journal of surgery 39 (8):1930–1935. doi:10.1007/s00268-015-3064-y CrossRefPubMed Sung TY, Lee YM, Yoon JH, Chung KW, Hong SJ (2015) Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases. World journal of surgery 39 (8):1930–1935. doi:10.​1007/​s00268-015-3064-y CrossRefPubMed
9.
Zurück zum Zitat Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH (1995) Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Archives of surgery (Chicago, Ill : 1960) 130 (8):892–897; discussion 898-899CrossRef Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH (1995) Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Archives of surgery (Chicago, Ill : 1960) 130 (8):892–897; discussion 898-899CrossRef
10.
Zurück zum Zitat Tavarelli M, Russo M, Terranova R, Scollo C, Spadaro A, Sapuppo G, Malandrino P, Masucci R, Squatrito S, Pellegriti G (2015) Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families. Frontiers in endocrinology 6:117. doi:10.3389/fendo.2015.00117 CrossRefPubMedPubMedCentral Tavarelli M, Russo M, Terranova R, Scollo C, Spadaro A, Sapuppo G, Malandrino P, Masucci R, Squatrito S, Pellegriti G (2015) Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families. Frontiers in endocrinology 6:117. doi:10.​3389/​fendo.​2015.​00117 CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP (1997) Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. The Journal of clinical endocrinology and metabolism 82 (11):3553–3562. doi:10.1210/jcem.82.11.4373 CrossRefPubMed Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP (1997) Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. The Journal of clinical endocrinology and metabolism 82 (11):3553–3562. doi:10.​1210/​jcem.​82.​11.​4373 CrossRefPubMed
12.
13.
Zurück zum Zitat Edge S, Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti, A. (2010) AJCC Cancer Staging Manual. vol 7th ed. New York. NY: Springer-Verlag, Edge S, Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti, A. (2010) AJCC Cancer Staging Manual. vol 7th ed. New York. NY: Springer-Verlag,
14.
Zurück zum Zitat Moses W, Weng J, Kebebew E (2011) Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid : official journal of the American Thyroid Association 21 (4):367–371. doi:10.1089/thy.2010.0256 CrossRef Moses W, Weng J, Kebebew E (2011) Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid : official journal of the American Thyroid Association 21 (4):367–371. doi:10.​1089/​thy.​2010.​0256 CrossRef
16.
Zurück zum Zitat Phillips D, McLachlan S, Stephenson A, Roberts D, Moffitt S, McDonald D, Ad’Hiah A, Stratton A, Young E, Clark F, et al. (1990) Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. The Journal of clinical endocrinology and metabolism 70 (3):742–746. doi:10.1210/jcem-70-3-742 CrossRefPubMed Phillips D, McLachlan S, Stephenson A, Roberts D, Moffitt S, McDonald D, Ad’Hiah A, Stratton A, Young E, Clark F, et al. (1990) Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. The Journal of clinical endocrinology and metabolism 70 (3):742–746. doi:10.​1210/​jcem-70-3-742 CrossRefPubMed
17.
Zurück zum Zitat Barbesino G, Chiovato L (2000) The genetics of Hashimoto’s disease. Endocrinol Metab Clin North Am 29 (2):357–374CrossRefPubMed Barbesino G, Chiovato L (2000) The genetics of Hashimoto’s disease. Endocrinol Metab Clin North Am 29 (2):357–374CrossRefPubMed
18.
Zurück zum Zitat Lee JH, Kim Y, Choi JW, Kim YS (2013) The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. European journal of endocrinology / European Federation of Endocrine Societies 168 (3):343–349. doi:10.1530/eje-12-0903 CrossRef Lee JH, Kim Y, Choi JW, Kim YS (2013) The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. European journal of endocrinology / European Federation of Endocrine Societies 168 (3):343–349. doi:10.​1530/​eje-12-0903 CrossRef
19.
Zurück zum Zitat Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Yamashita H, Shuto S (2002) Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World journal of surgery 26 (8):897–902. doi:10.1007/s00268-002-6615-y CrossRefPubMed Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Yamashita H, Shuto S (2002) Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World journal of surgery 26 (8):897–902. doi:10.​1007/​s00268-002-6615-y CrossRefPubMed
20.
Zurück zum Zitat Ito Y, Kakudo K, Hirokawa M, Fukushima M, Yabuta T, Tomoda C, Inoue H, Kihara M, Higashiyama T, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A (2009) Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 145 (1):100–105. doi:10.1016/j.surg.2008.08.004 CrossRefPubMed Ito Y, Kakudo K, Hirokawa M, Fukushima M, Yabuta T, Tomoda C, Inoue H, Kihara M, Higashiyama T, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A (2009) Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 145 (1):100–105. doi:10.​1016/​j.​surg.​2008.​08.​004 CrossRefPubMed
22.
Zurück zum Zitat Robenshtok E, Tzvetov G, Grozinsky-Glasberg S, Shraga-Slutzky I, Weinstein R, Lazar L, Serov S, Singer J, Hirsch D, Shimon I, Benbassat C (2011) Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid : official journal of the American Thyroid Association 21 (1):43–48. doi:10.1089/thy.2009.0406 CrossRef Robenshtok E, Tzvetov G, Grozinsky-Glasberg S, Shraga-Slutzky I, Weinstein R, Lazar L, Serov S, Singer J, Hirsch D, Shimon I, Benbassat C (2011) Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid : official journal of the American Thyroid Association 21 (1):43–48. doi:10.​1089/​thy.​2009.​0406 CrossRef
Metadaten
Titel
Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period
verfasst von
Kalin Vidinov
Dragomira Nikolova
Publikationsdatum
22.10.2016
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 1/2017
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-016-9456-1

Neu im Fachgebiet Pathologie

Overview of a comparative analysis of microsatellite instability and standard mismatch repair protein-deficiency tests in a large cancer cohort

  • Hauptreferate: Hauptprogramm der DGP

A retrospective analysis was carried out based on a large cancer patient cohort of our institute ( n  = 1306; collected from 2018 to 2023). dMMR was tested by four IHC reactions (MLH1 and PMS2 or MSH2 and MSH 6). Further, parallel pentaplex …

Molekulare Testung bei mesenchymalen Neoplasien: Was, wann und wie testen?

Mit dem weit verbreiteten Einsatz diverser molekularer Methoden in der histopathologischen Routinediagnostik hat die Tumorklassifikation in den letzten beiden Jahrzehnten signifikante Fortschritte gemacht. Dabei wurden zum einen zahlreiche …

Reconstructing 3D histological structures using machine learning (artificial intelligence) algorithms

  • Hauptreferate: Hauptprogramm der DGP

Artificial intelligence (AI) has recently been applied to pathological and medical image analysis with high sensitivity and specificity [ 1 , 2 ], aiding in various dental diagnostic techniques. The use of AI in image annotation has enhanced the …

Key considerations when implementing new diagnostic technologies in routine practice

  • Hauptreferate: Arbeitsgemeinschaften der DGP

This review explores several key considerations that are critical for implementing new diagnostic technologies into routine practice. These elements will provide a comprehensive guide for navigating the complexities of integrating cutting-edge …